Cargando…
Towards Inhibition of Vif-APOBEC3G Interaction: Which Protein to Target?
APOBEC proteins appeared in the cellular battle against HIV-1 as part of intrinsic cellular immunity. The antiretroviral activity of some of these proteins is overtaken by the action of HIV-1 Viral Infectivity Factor (Vif) protein. Since the discovery of APOBEC3G (A3G) as an antiviral factor, many a...
Autores principales: | Cadima-Couto, Iris, Goncalves, Joao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275931/ https://www.ncbi.nlm.nih.gov/pubmed/22347227 http://dx.doi.org/10.1155/2010/649315 |
Ejemplares similares
-
HIV-1 Vif and APOBEC3G: Multiple roads to one goal
por: Goncalves, Joao, et al.
Publicado: (2004) -
Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein
por: Stupfler, Benjamin, et al.
Publicado: (2021) -
Small molecules that inhibit Vif-induced degradation of APOBEC3G
por: Matsui, Masashi, et al.
Publicado: (2014) -
Structure of the Vif-binding domain of the antiviral enzyme APOBEC3G
por: Kouno, Takahide, et al.
Publicado: (2015) -
HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation
por: Mercenne, Gaëlle, et al.
Publicado: (2010)